Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VILDAGLIPTIN: 2,063 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
2,063
Total FAERS Reports
181 (8.8%)
Deaths Reported
1,064
Hospitalizations
2,063
As Primary/Secondary Suspect
122
Life-Threatening
20
Disabilities

First Report: 1975 · Latest Report: 20250916

What Are the Most Common VILDAGLIPTIN Side Effects?

#1 Most Reported
Pemphigoid
495 reports (24.0%)
#2 Most Reported
Hypoglycaemia
121 reports (5.9%)
#3 Most Reported
Acute kidney injury
120 reports (5.8%)

All VILDAGLIPTIN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Pemphigoid 495 24.0% 3 228
Hypoglycaemia 121 5.9% 5 89
Acute kidney injury 120 5.8% 4 108
Blood glucose increased 98 4.8% 2 30
Lactic acidosis 98 4.8% 13 86
Malaise 87 4.2% 1 29
Dyspnoea 84 4.1% 4 52
Drug ineffective 82 4.0% 0 30
Vomiting 72 3.5% 3 60
Diabetes mellitus 69 3.3% 6 16
Hyperglycaemia 69 3.3% 7 21
Weight decreased 66 3.2% 3 28
Fall 65 3.2% 5 43
Diarrhoea 63 3.1% 4 37
Diabetes mellitus inadequate control 62 3.0% 0 21
Blood pressure increased 61 3.0% 13 25
Pruritus 58 2.8% 0 26
Hypertension 55 2.7% 2 13
Blister 53 2.6% 1 31
Dizziness 53 2.6% 0 29

Who Reports VILDAGLIPTIN Side Effects? Age & Gender Data

Gender: 49.6% female, 50.4% male. Average age: 70.8 years. Most reports from: FR. View detailed demographics →

Is VILDAGLIPTIN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2001 1 1 1
2005 3 0 2
2006 1 0 0
2007 2 0 1
2008 4 3 1
2009 4 0 2
2010 7 0 3
2011 8 1 6
2012 16 1 3
2013 32 1 15
2014 75 12 45
2015 83 2 38
2016 91 5 61
2017 119 12 75
2018 205 36 134
2019 161 15 108
2020 89 9 56
2021 93 6 59
2022 33 1 27
2023 49 14 19
2024 74 2 39
2025 10 7 1

View full timeline →

What Is VILDAGLIPTIN Used For?

IndicationReports
Type 2 diabetes mellitus 814
Diabetes mellitus 529
Product used for unknown indication 508
Insulin-requiring type 2 diabetes mellitus 30
Blood glucose abnormal 9
Suicide attempt 8
Ketosis-prone diabetes mellitus 7
Blood glucose increased 6
Diabetes mellitus management 6
Parkinson's disease 6

VILDAGLIPTIN vs Alternatives: Which Is Safer?

VILDAGLIPTIN vs VILOXAZINE VILDAGLIPTIN vs VIMPAT VILDAGLIPTIN vs VIMSELTINIB VILDAGLIPTIN vs VINBLASTINE VILDAGLIPTIN vs VINCRISTINE VILDAGLIPTIN vs VINDESINE VILDAGLIPTIN vs VINORELBINE VILDAGLIPTIN vs VINORELBINE\VINORELBINE VILDAGLIPTIN vs VIREAD VILDAGLIPTIN vs VISIPAQUE

Official FDA Label for VILDAGLIPTIN

Official prescribing information from the FDA-approved drug label.